BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34397971)

  • 1. High Prevalence of Macrolide and Fluoroquinolone Resistance-Mediating Mutations in Mycoplasma genitalium-Positive Urine Specimens From Saskatchewan.
    Parmar NR; Mushanski L; Wanlin T; Lepe A; Lang A; Minion J; Dillon JR
    Sex Transm Dis; 2021 Sep; 48(9):680-684. PubMed ID: 34397971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Day MJ; Cole MJ; Fifer H; Woodford N; Pitt R
    Sex Transm Infect; 2022 May; 98(3):215-218. PubMed ID: 34088790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.
    Unemo M; Salado-Rasmussen K; Hansen M; Olsen AO; Falk M; Golparian D; Aasterød M; Ringlander J; Nilsson CS; Sundqvist M; Schønning K; Moi H; Westh H; Jensen JS
    Clin Microbiol Infect; 2018 May; 24(5):533-539. PubMed ID: 28923377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma genitalium prevalence and macrolide resistance-associated mutations and coinfection with Chlamydia trachomatis in Southern Jutland, Denmark.
    Desdorf R; Andersen NM; Chen M
    APMIS; 2021 Dec; 129(12):706-710. PubMed ID: 34580906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
    Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
    Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Mycoplasma genitalium and Antibiotic Resistance-Associated Mutations in Patients at a Sexually Transmitted Infection Clinic in Iceland, and Comparison of the S-DiaMGTV and Aptima Mycoplasma genitalium Assays for Diagnosis.
    Hilmarsdóttir I; Arnardóttir EM; Jóhannesdóttir ER; Valsdóttir F; Golparian D; Hadad R; Vigfússon HB; Unemo M
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32611793
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates.
    Hart T; Tang WY; Mansoor SAB; Chio MTW; Barkham T
    BMC Infect Dis; 2020 Apr; 20(1):314. PubMed ID: 32345231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of macrolide- and fluoroquinolone-resistant Mycoplasma genitalium strains in clinical specimens from men who have sex with men of two sexually transmitted infection practices in Berlin, Germany.
    Dumke R; Ziegler T; Abbasi-Boroudjeni N; Rust M; Glaunsinger T
    J Glob Antimicrob Resist; 2019 Sep; 18():118-121. PubMed ID: 31252154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain.
    Maldonado-Barrueco A; Rodríguez-Ayala M; Grandioso-Vas D; García-Clemente P; Guedez-López GV; García-Rodríguez J; Quiles-Melero I
    Rev Esp Quimioter; 2023 Jun; 36(3):310-313. PubMed ID: 36896655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
    Tagg KA; Jeoffreys NJ; Couldwell DL; Donald JA; Gilbert GL
    J Clin Microbiol; 2013 Jul; 51(7):2245-9. PubMed ID: 23658265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Macrolide and/or Fluoroquinolone Resistance Genes in
    Ljubin-Sternak S; Meštrović T; Marijan T; Anušić M; Šuto S; Vraneš J
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674404
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of
    Wang L; Li Z; Wan C; Tian X; Liu H; Li Y
    Int J STD AIDS; 2023 Jul; 34(8):518-524. PubMed ID: 36929876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
    Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
    J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and antibiotic resistance of
    Gratrix J; Plitt S; Turnbull L; Smyczek P; Brandley J; Scarrott R; Naidu P; Parker P; Blore B; Bull A; Shokoples S; Bertholet L; Martin I; Chernesky M; Read R; Singh A
    BMJ Open; 2017 Jul; 7(7):e016300. PubMed ID: 28698342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Pitt R; Fifer H; Woodford N; Alexander S
    Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma genitalium Antibiotic Resistance-Mediating Mutations in Canadian Women With or Without Chlamydia Trachomatis Infection.
    Chernesky MA; Jang D; Martin I; Hoang LMN; Naidu P; Levett PN; Wylie J; Rebbapragada A; Ratnam S; Smieja M; Weinbaum B; Getman D;
    Sex Transm Dis; 2017 Jul; 44(7):433-435. PubMed ID: 28608794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.